September 2017 Issue - Endovascular Today

Table of Contents

Issue

September 2017

SFA

The Forces Driving Care

Supplement

Evidence From the Next-Generation DCB

Delivering top-tier clinical outcomes.

In This Issue

Guest Chief Medical Editors' Page

Superficial Femoral Artery: The Forces Driving Care

By Gary M. Ansel, MD, FACC, and Koen Deloose, MD

Cover Stories

A US Perspective: SFA CTO Crossing: Is Perfection Possible?

A formal credentialing criteria for femoropopliteal chronic total occlusions.

By John A. Phillips, MD

A European Perspective: Valued Care and the Potential for CTO Credentialing

The current treatment landscape for complex superficial femoral artery lesions and recommendations for improvement.

By Luis Mariano Palena, MD; Efrem Gomez Jabalera, MD; and Marco Manzi, MD

Peripheral Vascular Care: A Clinical and Administrative Perspective

Michael R. Jaff, DO, answers questions posed by Gary M. Ansel, MD, FACC, and Koen Deloose, MD, on the challenges of his new role as hospital president and how new regulatory and reimbursement models might affect vascular care delivery.

With Michael R. Jaff, DO; Gary M. Ansel, MD, FACC; and Koen Deloose, MD

Perspectives: Does Care Drive Reimbursement or Vice Versa?

By Tony S. Das, MD, FACP, FACC; and Yann Gouëffic, MD, PhD

Vessel Preparation and Plaque Modification of Infrainguinal Lesions

Defining the terms, discussing the data, and reviewing perspectives on current practices.

By Ehrin J. Armstrong, MD, and Marianne Brodmann, MD

The Challenges of Calcium in Peripheral Artery Disease

Dr. Rocha-Singh discusses the available methods for calcium assessment and scoring, how calcium affects procedural success, and the goals of the VIVA calcium scoring unification initiative.

With Krishna Rocha-Singh, MD

What's Next in Drug-Eluting SFA Technology?

Juan Granada, MD, discusses potential next-generation advancements in drugs, delivery methods, and study.

With Juan F. Granada, MD, FACC

Ask the Experts: Perfect Pairing: Which Stent Properties Are the Best Match for Drug-Coated Balloons?

Experts weigh in on properties of available stent technology and which combinations could be used to improve femoropopliteal disease outcomes.

With Stavros Spiliopoulos, MD, PhD, EBIR; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; Mark W. Burket, MD; and Thomas Zeller, MD

Featured Technology

September 2017 Supplement

Evidence From the Next-Generation DCB

Delivering top-tier clinical outcomes.

In This Issue

September 2017 Supplement

Most Read Articles